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Plasmodium speciﬁc IgA has been detected in serum and breast milk among the endemic population but
the role it can play in vivo is not clear. In this report, we demonstrate the utility of Malaria speciﬁc IgA,
elicited by peptide sequences (referred as Mpep3 and Mpep4) of region VI of EBA-175 (PfrVI). Immu-
nization of mice with KLH tagged or untagged peptides of Mpep3, Mpep4 or with PfrVI have resulted in
speciﬁc IgA response that inhibits the in vitro invasion of Plasmodium falciparummerozoites. Mice having
the IgA speciﬁc to Mpep4 have exhibited higher tolerance to Plasmodium berghei ANKA parasitemia,
exhibited several fold lesser sequestration of infected RBC, lesser damage to microvasculature with no
signs of perivascular haemorrhage and lesser lung inﬂammation in comparison to unimmunized mice. In
addition, the immunized mice have B-cell population that secrete the IgA speciﬁc to PfrVI. These results
suggest that the IgA speciﬁc to these malarial antigens can confer signiﬁcant advantage to hosts and it
may also reduce the severity of malaria infection.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Plasmodium falciparum, which causes fatal and life-threatening
complications like cerebral and placental malaria, utilizes several
redundant ligands to invade erythrocyte membrane to evade im-
mune surveillance [1]. Among the ligands, EBA-175 is the primary
ligand for invasion by merozoites. The EBA-175, comprises several
regions viz. Regions I-VI, is secreted by microneme onto the surface
of merozoites and is shed at or around the point of invasion [2,3].
While the regions I and II have the Duffy Binding Domains, the
regions III-V have variable functions and the C-terminal Cysteine
rich region VI is followed by a transmembrane domain (TMD) with
a cytoplasmic tail (Fig. 1A). It is reported that the region VI of EBA-
175 (PfrVI) participates in the formation of tight junction complex
with host membrane, dimerization of the EBA-175 and also for
trafﬁcking to microneme. Moreover, the PfrVI has sequences that
are conserved across the DBL family proteins. For example, it con-
tains eight highly conserved Cys residues (Fig. 1B, marked in bold)
and a ROM4 cleavage site needed for shedding of EBA-175 form thecience, Savitribai Phule Pune
y).
r Inc. This is an open access articlejunctional complex for completion of the invasion cycle. Shedding
of this junctional complex occurs irrespective of EBA-175 being
used as a primary ligand or not [3]. However, the nature of immune
response elicited by this domain and its in vivo role has not been
investigated in detail.
Antibody response against region II and EBA-peptide 44 (42 aa
within the region V) can block the binding of native EBA-175 to
human erythrocytes and also inhibits the merozoite invasion
in vitro [2,4]. Importantly, antibodies against EBLs and RBLs are
elicited in a kinetic manner i.e. initially to EBA175, EBA181, EBA140
(involved in sialic acid-dependent pathway), and later to PfRh2 and
PfRh4 (involved in sialic acid -independent pathway) [1]. The suc-
cess of passive immunization also highlights the role of Immuno-
globulin (Ig) based therapies since anti-EBA-175 IgG has been able
to block the invasion by ~90% [5]. Further, animal models based on
passive immunization with mono speciﬁc antibodies (raised
against synthetic peptides) or adoptive transfer of B-cells (speciﬁc
to malarial antigens) have also highlighted the role of adaptive
immune response against malaria infection [6e9]. In addition,
susceptibility of B-cell-deﬁcient hosts has, once again, underlined
the role of antibodies in ﬁghting the infection [9].
Hence, it is curious whether or not antibody response, exclu-
sively directed towards themembrane proximal region of PfrVI, can
have any role during the erythrocyte invasion step. It appears thatunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Immune responses of Mpep3, Mpep4 and PfrVI in mice: A: Diagrammatic presentation of domains of EBA-175 of Plasmodium falciparum. The markings SS, F1, F2, rVI,
TMD respectively represent signal sequence, duffy binding domains 1 and 2, region VI and transmembrane domains. (B) Homology between PfrVI and PbArVI: The PfrVI and
PbArVI have 44% homology between them and the PfrVI contains a cleavage site (A'G) of PfROM4 protease. The peptides sequences, Mpep3 (17mer) and Mpep4 (18mer), used in the
study are underlined. (CeE) Immunoglobulin proﬁle elicited by the antigens Mpep3 (C), Mpep4 (D) and PfrVI(E) in C57BL/6 mice: The immunoglobulin isotype was determined by
ELISA. The antigen coated on the plate is shown below the group of bars and the isotype detected is shown below for each group. A sample with an OD value which were at least two
standard deviations (SD) higher from that of the negative controls (described in methods sections) were considered positive. (C) Represents the average data of one of the ﬁve
independent Mpep3 immunizations of C57BL/6 mice. (D) Represents the average data of seven independent immunizations of Mpep4 of C57BL/6 mice. (E) Represents the average
data of ﬁve independent PfrVI immunizations of C57BL/6 mice. The 'sol' and 'gel' form respectively represent the antigen, PfrVI, in solution (puriﬁed through Ni-NTA column) and
isolated from SDS-PAGE gel speciﬁc to the PfrVI band respectively. The number of mice used for obtaining the average for each bar is given below.
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cyte invasion step. In this regard, we have observed that the rVI
derived peptide sequences i.e. Mpep3 and Mpep4 elicit predomi-
nant IgA isotype in Balb/C background. Interestingly, endemic pa-
tient sera have also shown positive reactivity towards these
sequences. We have also detected the presence of B-cells speciﬁc to
Mpep3 and Mpep4 in immunized mice and the B-cells secrete IgA
in in vitro culture (under review else where). In view of these ob-
servations, we have attempted to understand the utility of this IgA
in the context of experimental animal infection. Since, the Mpep4
sequence has good homology with the rVI domain of Plasmodium
berghei ANKA (PbA), we have attempted to understand the role of
IgA, if any, during the onset of infection. Our results show that the
IgA can substantially improve the cerebral pathology of C57BL/6
mice. This can pave the way for understanding the role of IgA in
malarial infections.2. Materials and methods
2.1. Animal experimentation
All protocols were approved by the Institutional Animal Care
Committee of National Centre for Cell Science, Pune. Allexperiments on mice were conducted in pathogen free, approved
environment.
2.2. Peptide synthesis
All the peptides used were obtained from commercial sources
which were HPLC puriﬁed with >99% purity and stored at 80C in
dry power form in air tight container. All peptides have been
veriﬁed by MALDI and MSeMS analysis.
2.3. Cloning of EBA-175 (PfrVI)
The PfrVI construct (coding sequence shown in Fig. 1B), was
cloned into pET32aþ using NcoI and HindIII restriction sites and it
has 109 amino acid Thioredoxin protein at C-terminus to kill the
cytotoxicity associated with PfrVI expression alone. Removal of Trx
tag has resulted in precipitation and/or loss of yield. The construct
was veriﬁed by DNA sequencing.
2.4. Expression and puriﬁcation of PfrVI by Ni-NTA column
Puriﬁcation of recombinant PfrVI was essentially carried out
using Ni-NTA matrix. E. coli BL21(DE3) codonþ strain, transformed
0.00
0.40
0.80
1.20
1.60
0 1 3 4 5 6 8 10 rVI PIS
Mpep4
rVI
Day
O
D
 (4
50
nm
)
B
0
10
20
30
40
50
60
PIS
175 sera
Mpep4 sera
Pa
ra
si
te
 In
hi
bi
tio
n 
(%
) *
*
1:25 1:50 1:100 1:200 1:400
*
*
*
*
A
Fig. 2. In vitro invasion Assay: (A) Inhibition of Erythrocyte Invasion by immune
sera: (A) Inhibition of erythrocyte invasion at different dilutions of the indicated im-
mune sera. The data shown are an average of 3 independent experiments. (B) Absence
of IgA in ﬁrst infection by MRA-671: Post infection immunoglobulin proﬁle of un-
immunized control C57BL/6 mice. The sera of mice infected with MRA-671, collected
on day 0, 1, 3, 4, 5, 6, 8 and 10 after infection were examined by ELISA. A sample with
an OD value which was at least two standard deviations (SD) away from that of the
negative controls was considered positive.
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amp (100 mg/ml) at 37 C and induced with 0.5 mM IPTG (OD~ 0.6).
The bacterial pellet was sonicated in 10 mM Tris-phosphate buffer
(pH-8.0) containing 6M urea and 0.1% Triton-X100 and the resul-
tant supernatant was puriﬁed by Ni-NTA chromatography. The urea
was gradually decreased from 6M to 0M by washing the matrix
with buffer containing 20mM imidazole and the proteinwas eluted
with 250 mM imidazole containing 10% glycerol. The PfrVI was
conﬁrmed by MSeMS analysis.
2.5. Preparation of emulsion
Emulsion was prepared by adding 1:1 ratio of antigen and
Fruend's complete for 1st and incomplete adjuvants for all subse-
quent immunizations.
2.6. Immunization of mice
Female C57BL/6 (4e6 weeks), after collecting pre-immune sera
(PIS), were immunized with 5e10 mg of respective antigen in
40e50 ml of emulsion for 3 times on 0, 21 and 42 days through
subcutaneous route. After 7 days of each immunization, tail vein
blood (10 ml) was collected in PBS for the estimation of immune
response. We have observed that the IgA response is independent
of peptide conjugation to carrier agent such as KLH.
2.7. Preparation of antigen coated plates
The 96-well plates were coated with Mpep3 (1 mg/well) Mpep4
(1 mg/well) and PfrVI (0.3 mg/well) in bicarbonate buffer (pH 9.6) at
4 C by over-night incubation.
2.8. Enzyme-linked immunosorbent assay (ELISA)
The ELISA for detection of IgA has been carried out as described
earlier. Brieﬂy, antigen coated plates, were washed with 0.05%
Tween-20 in Tris-buffered saline (TBST, pH-8.0) thrice, blocked for
2 h with 1% gelatin (Bio-Rad) in TBST at RT. Plates were incubated
with 100 ml of appropriately diluted anti-sera after washing. The
bound Ig isotype was detected with 100 ml of HRP-conjugated
secondary antibodies viz. goat-anti-mouse IgA-HRP (Invitrogen;
Cat # 62-6720; Lot 575981A), rat anti-mouse IgG-HRP (Invitrogen;
Cat # 04-6020; Lot 692174A). The values of all controls were
deducted from each sample. A sample with an OD value with at
least two standard deviations (SD) higher from that of the negative
controls was considered positive. Data from the different groups
were compared with One Way ANOVA test using Sigma Plot.12
software and statistical signiﬁcance was determined.
2.9. In vitro invasion assay
In vitro invasion assays were performed exactly as described
earlier by using synchronised P. falciparum 3D7 cultures obtained
by sorbital treatment [4]. The plates were incubated in a humidiﬁed
gas chamber (~95% nitrogen, 4% CO2, 1%O2) for 16e24 h at 37 C.
After 24 h, Blood smear was examined under ﬂuorescence micro-
scope with Acridine-orange staining to assess the ring stage (fresh
invasion). Rate of inhibition of erythrocyte invasion was estimated
by following formula: Inhibition of Invasion (%) ¼ [1-parasitemia
(%) in treated wells/parasitemia (%) in control wells] x100 [10e12].
2.10. Mice infections
P. berghei ANKA-1 (PbA-1) was kindly gifted by Prof. Namita
Surolia, JNCASR, Bangalore, India. P. berghei ANKA (MRA-671) andP. berghei ANKA (MRA-311) were obtained fromMR4, ATCC, USA. All
strains of P. berghei ANKA were maintained exclusively either in
C57BL/6 or Balb/C female mice. None of the parasite strains used in
the study was interchanged between mice strains. All infection
experiments were conducted after 2e3 passages from a frozen vial.
All mice were infected with 5  104 infected red blood cells (iRBC)
through intra-peritoneal injection.2.11. Estimation of parasitaemia
Parasitaemia was estimated by microscopic observation of thin
blood smears on indicated days by staining with 50 mM Acridine
Orange (Invitrogen) after they were ﬁxed in absolute methenol for
30e60 s. Parasitaemia was estimated by calculating the percentage
of red blood cells infected in at least 10 microscopic ﬁelds by
counting a minimum of 1000 or more RBCs.2.12. Histopathology of brain tissue
Infectedmiceweremonitored daily and brain, lung, liver, kidney
and spleen were harvested from mice immediately after death.
Harvested organs were ﬁxed in 10% (v/v) formaldehyde in distilled
A. Kumar et al. / Biochemical and Biophysical Research Communications 464 (2015) 943e948946water. Fixed brain tissues were cut into two half through sagittal
axis and embedded in wax block. We have examined various pa-
rameters of the sagittal sections of the mice brain viz. sequestration
of infected RBC, cerebral hemorrhage, and damage of endothelial
lining in brain tissue by scoring the haematoxylin-eosin stained
section of the tissue at 20X magniﬁcation. A minimum of three
sagittal sections of each of the brain tissue with more than 50
images from each group were independently examined by
pathologist for deviations in cerebral pathology.
2.13. Quantiﬁcation of histopathology of brain section
Haematoxylin-Eosin stained thin (1m) sections of brain and
other tissues were examined by light microscopy. At least 50 im-
ages of sagittal sections containing blood vessels (or all vessels on
small or sparsely vascularized specimens) from each of the groups
were identiﬁed and scored for a variety of characteristics. These
included sequestration of infected RBCs (scored as 0 for no infected
RBC, 1 ¼ loosely packed with infected RBCs, 2 ¼ moderate packing
with infected RBCs and 3 ¼ highly packed infected RBCs with
obvious distortion). Similarly the states of endothelium lining of
brain vasculature and perivascular hemorrhage were scored as 0 if
intact and 1 for damaged areas. The degree of sequestration of
blood vessels, damage to the endothelial lining and perivascular
hemorrhage were expressed as percentage score (ratio of score
obtained/highest score for the characteristic per 100 observations.
One way ANNOVA was carried as described above.
3. Results and discussion
3.1. IgA response is centered on the N-terminal side of the Mpep3
and Mpep4
The antisera of C57BL/6 mice, immunized as described in
methods section, have exhibited IgA speciﬁc to Mpep3 (Fig. 1C),
Mpep4 (Fig. 1D) and PfrVI (Fig. 1E). It should be noted that theDPI PbA-1
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Fig. 3. Progression and Survival of PbA infection: Progression (A and C) and survival (B and
6 mice were immunized with Mpep4 and after 2 boosters on day 21 and day 42, the mice w
parasitemia was monitored every 36e48 h. The panels B (for control and immunized, n ¼ 05
of the Mpep4 immunized and the control mice. Panels A-D represents the data of one of trecombinant PfrVI is useful for veriﬁcation of the immune response
since it contains bothMpep3 andMpep4 sequences and hence, acts
as an independent antigen. We have also ascertained that the goat
anti-mouse IgA-HRP, used here, did not bind to mouse-IgG (data
not shown). The panels Fig. 1CeE indicate that both Mpep3, Mpep4
elicit IgA but not IgG response in about 30 independent immuni-
zations performed over 3 years with different antigen preparations.
However, the PfrVI elicits IgG in addition to the IgA (Fig. 1E). In view
of the non-requirement of conjugation we have used the HPLC
puriﬁed peptides (>99% purity) in all our immunizations. Although,
not dramatic, IgA response in Balb/C has been found to be always
stronger than that of C57BL/6 mice (data not shown). Moreover,
there is also no cross-reactivity by the observed IgA i.e. the IgA
speciﬁc to Mpep3 does not cross react with Mpep4 and vice versa
(data not shown). The panel E also illustrates that the IgA response
elicited by the PfrVI (for both in-solution and in-gel form of anti-
gens) is certainly centred on the Mpep4 sequence since Mpep4
coated wells showed strong IgA than IgG. Similar IgA response
against Mpep3 is also seen upon PfrVI immunization (data not
shown). Thus, both Mpep3 and Mpep4 have elicited only IgA
response, the PfrVI has elicited both IgA and IgG upon
immunization.3.2. Mpep3 and Mpep4 antisera inhibit erythrocyte invasion
in vitro
We next examined whether or not the observed IgA can
interfere in in vitro invasion of Plasmodium falciparum 3D7 (Pf)
merozoites. The in vitro invasion assay, in the presence of mice
serum, was done exact as described earlier [10e12]. As seen in
Fig. 2A, even with 50 fold diluted peptide anti-sera or anti-PfrVI
anti-sera, we have seen about ~50% inhibition of invasion. We
have consistently observed best inhibition with anti-Mpep4 anti-
serum in all our in vitro inhibition assays. This result suggests that
the IgA, speciﬁc to PfrVI and Mpep4, can inhibit in vitro invasion of
Pf merozoites.DPI PbA-1
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D) of Mpep4 immunized mice was monitored as described in methods section. C57BL/
ere challenged with either PbA-1 or MRA-671 strains on day 47 and the progression of
) and D (for control and immunized, n ¼ 6 and 7 respectively) show the survival pattern
hree independent experiments.
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To know the IgA isotype response after a fresh infectionwe have
examined themice sera collected on day 0,1, 3, 4, 5, 6, 8 and 10 after
infection with MRA-671. This is important because IgA in humans
was detected only among the individuals living in endemic areas
who have had multiple episodes of malarial infection (3 or more).
As shown in Fig. 2B, ﬁrst time infection of mice with PbA has not
elicited IgA response speciﬁc towards Mpep3 (although not ex-
pected due to lack of homology) or Mpep4 or PfrVI based on the
data collected over several independent infections even after day
12. This clearly indicates that ﬁrst infection doesn't lead to elicita-
tion of IgA against the sequences identiﬁed by us.
3.4. Mpep4 speciﬁc IgA improves survival and overall cerebral
pathology
In view of the above results, we have next examined the role ofFig. 4. IgA improves cerebral pathology of mice challenged with PbA: (AeH): Histology of
immunized mice were sacriﬁced on the last day of the curve (Fig. 3A and C) for quantitative h
A1, A2 (PbA-1) and C1 and C2 (MRA-671) are representative of brain sections of unimm
immunized mice. The panels E (PbA-1) and F(MRA-671) represent the quantitation of seque
controls (black bars) and Mpep4 immunized mice (grey bars). The Mpep4 immunized mice
sign of perivascular hemorrhages as compare to that of unimmunized mice while the control
and perivascular hemorrhages despite of similar peripheral parasitemia scored. The panels s
and Hi are representative lung sections of mice infected with PbA-1 and MRA-671 infecte
showed similar results.IgA in mice during infection. The homology between PfrVI and
PbArVI (Fig.1A) gave us the opportunity to probe the protective role,
if any, by the IgA. Two parasite strains were used in the study viz.
PbA-1,MRA-671 (MR4,USA). The characteristics of PbA-1 are similar
to the MRA-311 (data not shown), which usually exhibited average
parasitemia 30e50% and the average life span of infected mice is
8e13 days post infection (dpi) and the parasitemia and cerebral
pathology were similar to several published reports [13,14]. On the
other hand, the MRA-671 always exhibited typical parasitemia in
the range 12e18% and an average life span of 8e13 days post
infection (dpi) to that of control mice.
Immunization of mice with three different doses 5 mg, 10 mg and
20 mg of Mpep4 have elicited strong IgA immune response and the
titres of the individual subjects were similar among the group of
mice studied. In mice immunized with 5 mg of Mpep4, the pro-
gression of PbA-1 was slower initially but reached ~40% in 11 days
dpi in comparison to the control mice for which the parasitemia
reachedover 55%byday8 (Fig. 3A). Similarly for theMRA-671 strain,brain sections of the infected Mpep4 immunized C57 BL/6 mice: The controls and
istopathological examination of the brain sections as described in methods. The panels
unized, infected controls and the B1, B2 (PbA-1) D1, D2 (MRA-671) were of Mpep4
stration, hemorrhages and damage to epithelial lining observed in various sections of
consistently showed far less sequestration and no damage to the microvasculature or
mice showed higher iRBC sequestration, damaged epithelial lining of microvasculature
hown were a representative of three repetitions. The panels labeled with Gc, Hc and Gi
d mice. This data shown is a representative of three independent experiments which
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was slower (Fig. 3C) and reached parasitemia upto 60% and survived
at least 15 days longer (Fig. 3BeD) whereas the unimmunized
control mice died with 12e15 % parasitemia. For all the mice that
survived, the brains sections of the mice were examined by histo-
pathology. We have speciﬁcally looked for sequestration of infected
RBC (iRBC) in the brain tissue, perivascular hemorrhage and damage
to endothelial lining in the H&E stained sections of the brains. His-
topathology of brain sections of mice immunized with Mpep4 (for
various immunization doses) in both strains (PbA-1 and MRA-671)
clearly showed several fold lesser sequestration of iRBC, little or
no damage to microvasculature and no sign of perivascular hem-
orrhage (Fig. 4, panels B1, B2 and D1 and D2) in comparison to the
brain sections of unimmunized C57 mice which showed higher
sequestrationof iRBC, damagedepithelial liningofmicrovasculature
and frequent perivascular hemorrhages (Fig. 4, panels A1, A2, C1, and
C2). About >75% tissue sections examined, we have noted that the
small blood vessels have remained intact and the damage to endo-
thelial lining is observed only in case of large blood vessels aswell as
hemorrhages (Fig. 4E and F). A similar, markedly improved pathol-
ogy is also seen in case of lungs of PbA infected mice upon immu-
nization. The panels, Fig. 4Gc and Hc, show extreme congestion of
the alveolar space while the immunized mice have a normal like
appearance (Fig. 4Gi and Hi) despite the high parasitemia. These
results suggest us that the IgA can offer protection against parasite
mediated sequestration and damage of endothelial lining. Overall,
the immunizedmice did not exhibit any symptoms of experimental
cerebral malaria described in the literature.
Our study, for the ﬁrst time, demonstrates the utility of anti-
malarial IgA. Based on the literature, it is clear that malaria induces
high level of IgGand the resultant response, inprinciple, can compete
with the FcR occupancy. In this regard, the IgA described here can
have an obvious advantage. In addition to this, antibody based
therapies involving both IgG1 and IgG3 subtype may be disadvanta-
geous since they can bind FcgRs present on cells (platelets, B-cells,
endothelial cells and placental tissue) that do not eliminate
P. falciparum and may lead to triggering of inhibitory FcgRIIb as
observed among endemic patients. It is apparent form the literature
that the immunoglobulin subtypes IgM, IgG and IgE were all impli-
cated invariouspathologies i.e. the pathologyassociatedwith rosette
formation, placentalmalaria and severemalaria [9]. Interestingly, the
IgA isotype has not been shown to be responsible for any undesired
pathology in malarial infection. This possibility opens-up the debate
on IgA based anti-malarial therapy. In the study involving western
Kenyan children samples, it was observed that the IgA associated
immune complex has a protective effect to cerebral pathology, unlike
IgG1, IgG3 and IgE associated immune complexes [15]. In another
study, the retinoic acid, a major oxidative metabolite of Vitamin A,
induces IgA isotype switchingmainly throughRARa in human B cells
and Vitamin A deﬁciency increases the mortality in African children,
and malaria being an all-important cause of death of children of this
age [16e18]. This is because human FcaR is constitutively expressed
on monocytes, neutrophils, eosinophils, Kupffer cells and dendritic
cells, which can capture and process the IgA opsonized parasite. It is
relevant to note that the receptor for IgA in mice (human CD89
equivalent)hasnot beenconﬁrmed.Moreover, IgA is the secondmost
abundant antibody (~1e4% of total serum protein) in humans and
mice. Moreover, the malaria associated IgA i.e. positive serum of
endemic patients, also appears to inhibit the in vitro invasion of
P. falciparum merozoites [19]. Notably, the IgA, detected among the
endemic Indian population, was signiﬁcant only among individuals
whohadmultiple clinical attacks ofplasmodiuminfection. Itwasalso
reported that the IgA titerwere found to increasewith the age among
the seropositive individuals.
Summarily, our study will serve as an important starting pointfor the development of IgA based therapy against malaria infection.
Monoclonal antibodies against Mpep4 sequence may serve as a
potent antibody mediated therapy to provide an alternative
approach to combat malaria successfully.
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